IRVINE, Calif., April 17, 2024 (Globe Newswire) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) is on a mission to treat and transform the lives of patients suffering from venous disease. A medical device company. The company announced today that it will report its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the announcement, Inari will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET. Discuss financial results and recent highlights.
Interested parties can access the live call by phone by dialing 844-825-9789 for domestic calls or 412-317-5180 for international calls. Live webinars can be accessed by visiting the events section of the Inari Investor Relations website or by registering here. A replay of the webinar will be available immediately after the call ends and will be archived on Inari's website.
About Inari Medical Co., Ltd.
Patients first. There are no small plans. Please take care of each other. These are the fundamental principles that form the ethos of Inari Medical. We are committed to improving lives in amazing ways by creating innovative solutions to both unmet and underserved health needs. In addition to purpose-built solutions, we leverage our education, clinical research and program development capabilities to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous diseases, including venous thromboembolism and chronic venous disease. It's just the beginning. For more information, please visit www.inarimedical.com. You can also connect with us on LinkedIn, X (Twitter), and Instagram.
Investor contact information:
John Hsu, CFA
Vice President of Investor Relations
949-658-3889
IR@inarimedical.com
